2Lun·
2
2 Comentarios

Classic the shareholder tip
1
@Frei possible. I have them in my portfolio and am considering whether I should buy more here. Or whether I prefer other pharmaceutical stocks because the sector is underrepresented in the portfolio.
Únase a la conversación